HLS Therapeutics Inc. (TSX:HLS)
Canada · Delayed Price · Currency is CAD 4.590
-0.050 (-1.08%)
May 21, 2026, 4:00 PM EST
HLS Therapeutics Market Cap
HLS Therapeutics has a market cap or net worth of CAD 143.55 million as of May 21, 2026. Its market cap has increased by 5.74% in one year.
Market Cap
143.55M
Enterprise Value
189.93M
Revenue
77.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.59
Market Cap Chart
Since March 15, 2018, HLS Therapeutics's market cap has decreased from 317.91M to 143.55M, a decrease of -54.85%. That is a compound annual growth rate of -9.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 145.11M | -3.73% |
| Dec 31, 2025 | 150.74M | 20.64% |
| Dec 31, 2024 | 124.95M | -1.37% |
| Dec 29, 2023 | 126.68M | -60.20% |
| Dec 30, 2022 | 318.33M | -34.60% |
| Dec 31, 2021 | 486.77M | -14.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurora Cannabis | 270.21M |
| TerrAscend | 261.58M |
| Organigram Global | 208.14M |
| Cardiol Therapeutics | 202.49M |
| Auxly Cannabis Group | 200.54M |
| Cannara Biotech | 169.91M |
| BioSyent | 165.17M |
| Ascend Wellness Holdings | 128.53M |